These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25778529)

  • 1. Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation.
    Popat U; Mehta RS; Rezvani K; Fox P; Kondo K; Marin D; McNiece I; Oran B; Hosing C; Olson A; Parmar S; Shah N; Andreeff M; Kebriaei P; Kaur I; Yvon E; de Lima M; Cooper LJ; Tewari P; Champlin RE; Nieto Y; Andersson BS; Alousi A; Jones RB; Qazilbash MH; Bashir Q; Ciurea S; Ahmed S; Anderlini P; Bosque D; Bollard C; Molldrem JJ; Chen J; Rondon G; Thomas M; Miller L; Wolpe S; Simmons P; Robinson S; Zweidler-McKay PA; Shpall EJ
    Blood; 2015 May; 125(19):2885-92. PubMed ID: 25778529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-fucosylated CB CD34
    Robinson SN; Thomas MW; Simmons PJ; Lu J; Yang H; Javni JA; Shpall EJ; Zweidler-Mckay PA
    Cytotherapy; 2017 Feb; 19(2):285-292. PubMed ID: 27919572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow.
    Xia L; McDaniel JM; Yago T; Doeden A; McEver RP
    Blood; 2004 Nov; 104(10):3091-6. PubMed ID: 15280192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making a little go a long way..
    Davies SM
    Blood; 2015 May; 125(19):2877-8. PubMed ID: 25953973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
    Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
    Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ(null) mice.
    Robinson SN; Simmons PJ; Thomas MW; Brouard N; Javni JA; Trilok S; Shim JS; Yang H; Steiner D; Decker WK; Xing D; Shultz LD; Savoldo B; Dotti G; Bollard CM; Miller L; Champlin RE; Shpall EJ; Zweidler-McKay PA
    Exp Hematol; 2012 Jun; 40(6):445-56. PubMed ID: 22306295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enforced fucosylation of neonatal CD34+ cells generates selectin ligands that enhance the initial interactions with microvessels but not homing to bone marrow.
    Hidalgo A; Frenette PS
    Blood; 2005 Jan; 105(2):567-75. PubMed ID: 15367439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment.
    Robinson SN; Thomas MW; Simmons PJ; Lu J; Yang H; Parmar S; Liu X; Shah N; Martín-Antonio B; Bollard C; Dotti G; Savoldo B; Cooper LJ; Najjar A; Rezvani K; Kaur I; McNiece IK; Champlin RE; Miller LP; Zweidler-McKay PA; Shpall EJ
    Cytotherapy; 2014 Jan; 16(1):84-9. PubMed ID: 24094497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fucosyltransferase VII improves the function of selectin ligands on cord blood hematopoietic stem cells.
    Wan X; Sato H; Miyaji H; McDaniel JM; Wang Y; Kaneko E; Gibson B; Mehta-D'Souza P; Chen Y; Dozmorov M; Miller LP; Goodman J; Sun Z; Xia L
    Glycobiology; 2013 Oct; 23(10):1184-91. PubMed ID: 23899669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.
    Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of ex vivo expanded cord blood.
    Shpall EJ; Quinones R; Giller R; Zeng C; Baron AE; Jones RB; Bearman SI; Nieto Y; Freed B; Madinger N; Hogan CJ; Slat-Vasquez V; Russell P; Blunk B; Schissel D; Hild E; Malcolm J; Ward W; McNiece IK
    Biol Blood Marrow Transplant; 2002; 8(7):368-76. PubMed ID: 12171483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cord-blood engraftment with ex vivo mesenchymal-cell coculture.
    de Lima M; McNiece I; Robinson SN; Munsell M; Eapen M; Horowitz M; Alousi A; Saliba R; McMannis JD; Kaur I; Kebriaei P; Parmar S; Popat U; Hosing C; Champlin R; Bollard C; Molldrem JJ; Jones RB; Nieto Y; Andersson BS; Shah N; Oran B; Cooper LJ; Worth L; Qazilbash MH; Korbling M; Rondon G; Ciurea S; Bosque D; Maewal I; Simmons PJ; Shpall EJ
    N Engl J Med; 2012 Dec; 367(24):2305-15. PubMed ID: 23234514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide.
    Horwitz ME; Wease S; Blackwell B; Valcarcel D; Frassoni F; Boelens JJ; Nierkens S; Jagasia M; Wagner JE; Kuball J; Koh LP; Majhail NS; Stiff PJ; Hanna R; Hwang WYK; Kurtzberg J; Cilloni D; Freedman LS; Montesinos P; Sanz G
    J Clin Oncol; 2019 Feb; 37(5):367-374. PubMed ID: 30523748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft.
    Wagner JE; Brunstein CG; Boitano AE; DeFor TE; McKenna D; Sumstad D; Blazar BR; Tolar J; Le C; Jones J; Cooke MP; Bleul CC
    Cell Stem Cell; 2016 Jan; 18(1):144-55. PubMed ID: 26669897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a surface antigen (MA6) by peripheral blood CD34+ cells is correlated with improved platelet engraftment and may explain delayed platelet engraftment following cord blood transplantation.
    Simmons PJ; Robinson SN; Munsell MF; Thomas MW; Javni JA; Brouard N; Zweidler-McKay PA; Shpall EJ
    Stem Cells Dev; 2015 May; 24(9):1066-72. PubMed ID: 25674667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders.
    Kwon M; Bautista G; Balsalobre P; Sánchez-Ortega I; Serrano D; Anguita J; Buño I; Fores R; Regidor C; García Marco JA; Vilches C; de Pablo R; Fernández MN; Gayoso J; Duarte R; Díez-Martín JL; Cabrera R
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2015-22. PubMed ID: 25255162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.
    Gonzalo-Daganzo R; Regidor C; Martín-Donaire T; Rico MA; Bautista G; Krsnik I; Forés R; Ojeda E; Sanjuán I; García-Marco JA; Navarro B; Gil S; Sánchez R; Panadero N; Gutiérrez Y; García-Berciano M; Pérez N; Millán I; Cabrera R; Fernández MN
    Cytotherapy; 2009; 11(3):278-88. PubMed ID: 19308773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment.
    Horwitz ME; Chao NJ; Rizzieri DA; Long GD; Sullivan KM; Gasparetto C; Chute JP; Morris A; McDonald C; Waters-Pick B; Stiff P; Wease S; Peled A; Snyder D; Cohen EG; Shoham H; Landau E; Friend E; Peleg I; Aschengrau D; Yackoubov D; Kurtzberg J; Peled T
    J Clin Invest; 2014 Jul; 124(7):3121-8. PubMed ID: 24911148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
    Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
    Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.
    Mehta RS; Saliba RM; Cao K; Kaur I; Rezvani K; Chen J; Olson A; Parmar S; Shah N; Marin D; Alousi A; Hosing C; Popat U; Kebriaei P; Champlin R; de Lima M; Skerrett D; Burke E; Shpall EJ; Oran B
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1359-1366. PubMed ID: 28506845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.